
A new study that found the risk of Long COVID doubled in children following SARS-C0V-2 reinfection made mainstream headlines this week.

During today’s United Nations (UN) event “Healthy Indoor Air: A Global Call to Action,” advocate Violet Affleck spoke about how clean air and masking are vital tools to address the ongoing COVID-19 pandemic.

A drug originally developed for celiac disease was found to be safe and effective in treating a post-COVID syndrome in children, according to a new paper published in Science Translational Medicine.

The biotech company Invivyd, which makes the COVID-19 monoclonal antibody Pemgarda, announced this week that it has launched the SPEAR Study Group to explore the drug for Long COVID and post-vaccine syndrome (PVS).

Pregnant people infected with SARS-CoV-2 during their first trimester were more likely to have smaller newborns, according to a new study in Pediatric Research.

A new National Institutes of Health RECOVER program study in JAMA Pediatrics found that around one in seven children under age six with a prior SARS-CoV-2 infection met the probable diagnostic criteria for Long COVID. Studying over 1,000 infants, toddlers, and preschool-aged children, researchers revealed differences in how Long COVID presented between age groups.




Experts who spoke with The Sick Times brought up many different reasons why developing new drugs for children with Long COVID has moved at such a glacial pace. Many pharmaceutical companies might not see Long COVID as profitable. And running trials in children is complex and expensive, as they can have different symptoms and underlying…
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance